The use of antibiotics is common in the treatment of COVID–19, but adequate evaluation is
lacking. This study aimed to evaluate the effect of early antibiotic use in non-severe COVID …

Objectives The use of antibiotics was common in some countries during the early phase of
the coronavirus disease 2019 (COVID-19) pandemic, but adequate evaluation remains …

Introduction. Patients with moderate and severe COVID-19 generally receive antibiotic
therapy with consideration of the possibility of co-infection or secondary bacterial infection …

Background Debate continues regarding the usefulness and benefits of wide prescription of
antibiotics in patients hospitalized with coronavirus disease 2019 (COVID-19). Methods All …

This scoping review provides new evidence on the prevalence and patterns of global
antimicrobial use in the treatment of COVID-19 patients; identifies the most commonly used …

Background: To determine the potential risk factor of COVID-19 severity and length of
hospitalization, the association between multiple antibiotics administration and the risk of …

Background Literature suggests that antibiotic prescribing in COVID-19 patients is high,
despite low rates of confirmed bacterial infection. There are little data on what drives …

Background: Since the beginning of the COVID-19 pandemic, empiric antibiotics (ATBs)
have been prescribed on a large scale in both in-and outpatients. We aimed to assess the …

This scoping review provides new evidence on the prevalence and patterns of global
antimicrobial use in the treatment of COVID-19 patients; identifies the most commonly used …

Background: COVID-19 imposes challenges in antibiotic decision-making due to similarities
between bacterial pneumonia and moderate to severe COVID-19. We evaluated the effects …